{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:28:08Z","timestamp":1791293288332,"version":"4.1.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Disturbances in respiration are common and debilitating features of Rett syndrome (RTT). A previous study showed that the 5-HT1a receptor agonist (R)-(+)-8-hydroxy-dipropyl-2-aminotetralin hydrobromide (8-OH-DPAT) significantly reduced the incidence of apnea and the irregular breathing pattern in a mouse model of the disorder. 8-OH-DPAT, however, is not available for clinical practice. Sarizotan, a full 5-HT1a agonist and a dopamine D2\u2013like agonist\/partial agonist, has been used in clinical trials for the treatment of l-dopa\u2013induced dyskinesia. The purpose of this study was to evaluate the effects of sarizotan on respiration and locomotion in mouse models of RTT. Studies were performed in Bird and Jaenisch strains of methyl-CpG\u2013binding protein 2-\u2013deficient heterozygous female and Jaenisch strain Mecp2 null male mice and in knock-in heterozygous female mice of a common nonsense mutation (R168X). Respiratory pattern was determined with body plethysmography, and locomotion was determined with open-field recording. Sarizotan or vehicle was administered 20 minutes before a 30-minute recording of respiratory pattern or motor behavior. In separate studies, a crossover design was used to administer the drug for 7 and for 14 days. Sarizotan reduced the incidence of apnea in all three RTT mouse models to approximately 15% of their pretreatment levels. The irregular breathing pattern was corrected to that of wild-type littermates. When administered for 7 or 14 days, apnea decreased to 25 to 33% of the incidence seen with vehicle. This study indicates that the clinically approved drug sarizotan is an effective treatment for respiratory disorders in mouse models of RTT.<\/jats:p>","DOI":"10.1165\/rcmb.2013-0372oc","type":"journal-article","created":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T16:16:46Z","timestamp":1401639406000},"page":"1031-1039","source":"Crossref","is-referenced-by-count":67,"title":["Effect of Sarizotan, a 5-HT1a and D2-Like Receptor Agonist, on Respiration in Three Mouse Models of Rett Syndrome"],"prefix":"10.1093","volume":"50","author":[{"given":"Ana P.","family":"Abdala","sequence":"first","affiliation":[{"name":"Department of Physiology and Pharmacology, Medical Sciences Building, University of Bristol, Bristol, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Lioy","sequence":"additional","affiliation":[{"name":"Vollum Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh K.","family":"Garg","sequence":"additional","affiliation":[{"name":"Vollum Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Knopp","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics & Gynecology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian F. R.","family":"Paton","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Medical Sciences Building, University of Bristol, Bristol, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Bissonnette","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics & Gynecology, and"},{"name":"Cell & Developmental Biology, Oregon Health and Science University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,6,1]]},"reference":[{"key":"2026030623181946700_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1042\/BST0360575","article-title":"The methyl-CpG-binding protein MeCP2 and neurological disease","volume":"36","author":"Bird","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"2026030623181946700_bib2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"2026030623181946700_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/adc.85.1.29","article-title":"Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder","volume":"85","author":"Julu","year":"2001","journal-title":"Arch Dis Child"},{"key":"2026030623181946700_bib4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/adc.63.9.1039","article-title":"Hyperventilation in the awake state: potentially treatable component of Rett syndrome","volume":"63","author":"Southall","year":"1988","journal-title":"Arch Dis Child"},{"key":"2026030623181946700_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1203\/01.pdr.0000238302.84552.d0","article-title":"Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome","volume":"60","author":"Weese-Mayer","year":"2006","journal-title":"Pediatr Res"},{"key":"2026030623181946700_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nature10214","article-title":"A role for glia in the progression of Rett\u2019s syndrome","volume":"475","author":"Lioy","year":"2011","journal-title":"Nature"},{"key":"2026030623181946700_bib7","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/brain\/aws096","article-title":"Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome","volume":"135","author":"Robinson","year":"2012","journal-title":"Brain"},{"key":"2026030623181946700_bib8","doi-asserted-by":"crossref","first-page":"18208","DOI":"10.1073\/pnas.1012104107","article-title":"Correction of respiratory disorders in a mouse model of Rett syndrome","volume":"107","author":"Abdala","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030623181946700_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1113\/jphysiol.1994.sp020116","article-title":"5-HT-1A receptor-mediated modulation of medullary expiratory neurones in the cat","volume":"476","author":"Lalley","year":"1994","journal-title":"J Physiol"},{"key":"2026030623181946700_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.molmed.2003.10.010","article-title":"Serotonin receptors: guardians of stable breathing","volume":"9","author":"Richter","year":"2003","journal-title":"Trends Mol Med"},{"key":"2026030623181946700_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00702-003-0094-7","article-title":"Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile","volume":"111","author":"Bartoszyk","year":"2004","journal-title":"J Neural Transm"},{"key":"2026030623181946700_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/mds.21226","article-title":"Sarizotan as a treatment for dyskinesias in Parkinson\u2019s disease: a double-blind placebo-controlled trial","volume":"22","author":"Goetz","year":"2007","journal-title":"Mov Disord"},{"key":"2026030623181946700_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00002826-200403000-00003","article-title":"Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study)","volume":"27","author":"Olanow","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"2026030623181946700_bib14","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1098\/rstb.2009.0074","article-title":"Pontine respiratory activity involved in inspiratory\/expiratory phase transition","volume":"364","author":"Morschel","year":"2009","journal-title":"Philo Trans R Soc Lond B Biol Sci"},{"key":"2026030623181946700_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat Genet"},{"key":"2026030623181946700_bib16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat Genet"},{"key":"2026030623181946700_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00109-010-0704-4","article-title":"Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model","volume":"89","author":"Brendel","year":"2011","journal-title":"J Mol Med (Berl)"},{"key":"2026030623181946700_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2007.08.039","article-title":"Ube3a mRNA and protein expression are not decreased in Mecp2R168X mutant mice","volume":"1180","author":"Lawson-Yuen","year":"2007","journal-title":"Brain Res"},{"key":"2026030623181946700_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1152\/jappl.1983.55.1.250","article-title":"Two-sidearm tracheal cannula for respiratory airflow measurements in small animals","volume":"55","author":"Mortola","year":"1983","journal-title":"J Appl Physiol"},{"key":"2026030623181946700_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1203\/01.pdr.0000203157.31924.4a","article-title":"Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice","volume":"59","author":"Bissonnette","year":"2006","journal-title":"Pediatr Res"},{"key":"2026030623181946700_bib21","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1523\/JNEUROSCI.4373-05.2005","article-title":"Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice","volume":"25","author":"Viemari","year":"2005","journal-title":"J Neurosci"},{"key":"2026030623181946700_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-0270(95)00147-6","article-title":"A working heart-brainstem preparation of the mouse","volume":"65","author":"Paton","year":"1996","journal-title":"J Neurosci Methods"},{"key":"2026030623181946700_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1006\/taap.1996.0225","article-title":"An analysis of dimethylsulfoxide-induced action potential block: a comparative study of DMSO and other aliphatic water soluble solutes","volume":"140","author":"Larsen","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"2026030623181946700_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0005-2736(86)90053-2","article-title":"Effects of dimethylsulfoxide on membrane currents of neuroblastoma x glioma hybrid cell","volume":"856","author":"Jourdon","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"2026030623181946700_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5414\/CPP45271","article-title":"Pharmacokinetics of sarizotan after oral administration of single and repeat doses in healthy subjects","volume":"45","author":"Kr\u00f6sser","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2026030623181946700_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jmg.2006.045260","article-title":"Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation","volume":"44","author":"Archer","year":"2007","journal-title":"J Med Genet"},{"key":"2026030623181946700_bib27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"2026030623181946700_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.resp.2011.02.002","article-title":"The benzodiazepine midazolam mitigates the breathing defects of Mecp2-deficient mice","volume":"177","author":"Voituron","year":"2011","journal-title":"Respir Physiol Neurobiol"},{"key":"2026030623181946700_bib29","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J Neurosci"},{"key":"2026030623181946700_bib30","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1152\/japplphysiol.01361.2011","article-title":"7,8-dihydroxyflavone (7,8-dhf) exhibits therapeutic efficacy in a mouse model of rett syndrome","volume":"112","author":"Johnson","year":"2012","journal-title":"J Appl Physiol"},{"key":"2026030623181946700_bib31","doi-asserted-by":"crossref","first-page":"17230","DOI":"10.1523\/JNEUROSCI.2951-12.2012","article-title":"Anxiety-related mechanisms of respiratory dysfunction in a mouse model of Rett syndrome","volume":"32","author":"Ren","year":"2012","journal-title":"J Neurosci"},{"key":"2026030623181946700_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnint.2011.00006","article-title":"Habituation without nmda receptor-dependent desensitization of hering-breuer apnea reflex in a mecp2 mutant mouse model of rett syndrome","volume":"5","author":"Song","year":"2011","journal-title":"Front Integr Neurosci"},{"key":"2026030623181946700_bib33","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1523\/JNEUROSCI.0865-11.2012","article-title":"A TrkB small molecule partial agonist rescues TrkB phosphorylation deficits and improves respiratory function in a mouse model of Rett syndrome","volume":"32","author":"Schmid","year":"2012","journal-title":"J Neurosci"},{"key":"2026030623181946700_bib34","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities","volume":"106","author":"Samaco","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030623181946700_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2005.05.056","article-title":"Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse","volume":"386","author":"Ide","year":"2005","journal-title":"Neurosci Lett"},{"key":"2026030623181946700_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2202-12-47","article-title":"Biogenic amines and their metabolites are differentially affected in the Mecp2-deficient mouse brain","volume":"12","author":"Panayotis","year":"2011","journal-title":"BMC Neurosci"},{"key":"2026030623181946700_bib37","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/hmg\/ddn062","article-title":"A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome","volume":"17","author":"Samaco","year":"2008","journal-title":"Hum Mol Genet"},{"key":"2026030623181946700_bib38","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1523\/JNEUROSCI.4729-07.2008","article-title":"Defects in breathing and thermoregulation in mice with near-complete absence of central serotonin neurons","volume":"28","author":"Hodges","year":"2008","journal-title":"J Neurosci"},{"key":"2026030623181946700_bib39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1126\/science.1205295","article-title":"Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition","volume":"333","author":"Ray","year":"2011","journal-title":"Science"},{"key":"2026030623181946700_bib40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1113\/jphysiol.2006.119966","article-title":"Breathing dysfunctions associated with impaired control of postinspiratory activity in Mecp2-\/y knockout mice","volume":"579","author":"Stettner","year":"2007","journal-title":"J Physiol"},{"key":"2026030623181946700_bib41","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1460-9568.2006.04981.x","article-title":"The K\u00f6lliker-Fuse nucleus gates the postinspiratory phase of the respiratory cycle to control inspiratory off-switch and upper airway resistance in rat","volume":"24","author":"Dutschmann","year":"2006","journal-title":"Eur J Neurosci"},{"key":"2026030623181946700_bib42","author":"Dhingra"},{"key":"2026030623181946700_bib43","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/jnr.22312","article-title":"Progressive noradrenergic deficits in the locus coeruleus of Mecp2 deficient mice","volume":"88","author":"Roux","year":"2010","journal-title":"J Neurosci Res"},{"key":"2026030623181946700_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2008.09.045","article-title":"Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse","volume":"447","author":"Roux","year":"2008","journal-title":"Neurosci Lett"},{"key":"2026030623181946700_bib45","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1460-9568.2007.05466.x","article-title":"Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome","volume":"25","author":"Roux","year":"2007","journal-title":"Eur J Neurosci"},{"key":"2026030623181946700_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.resp.2007.08.009","article-title":"Oral treatment with desipramine improves breathing and life span in rett syndrome mouse model","volume":"60","author":"Zanella","year":"2008","journal-title":"Respir Physiol Neurobiol"},{"key":"2026030623181946700_bib47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"2026030623181946700_bib48","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1523\/JNEUROSCI.1810-06.2006","article-title":"Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice","volume":"26","author":"Wang","year":"2006","journal-title":"J Neurosci"},{"key":"2026030623181946700_bib49","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1523\/JNEUROSCI.5503-09.2010","article-title":"Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice","volume":"30","author":"Kline","year":"2010","journal-title":"J Neurosci"},{"key":"2026030623181946700_bib50","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.0812394106","article-title":"Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice","volume":"106","author":"Tropea","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026030623181946700_bib51","doi-asserted-by":"crossref","first-page":"R1829","DOI":"10.1152\/ajpregu.00057.2009","article-title":"D1\/D2-dopamine receptor agonist dihydrexidine stimulates inspiratory motor output and depresses medullary expiratory neurons","volume":"296","author":"Lalley","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026030623181946700_bib52","first-page":"353","article-title":"Microcircuitry of the direct and indirect pathways of the basal ganglia","volume":"86","author":"Smith","year":"1998","journal-title":"Neuroscience"},{"key":"2026030623181946700_bib53","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nature09159","article-title":"Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry","volume":"466","author":"Kravitz","year":"2010","journal-title":"Nature"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/50\/6\/1031\/67118061\/ajrcmb_50_6_1031.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/50\/6\/1031\/67118061\/ajrcmb_50_6_1031.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:18:30Z","timestamp":1772857110000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/50\/6\/1031\/8491876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,1]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,6,1]]},"published-print":{"date-parts":[[2014,6,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2013-0372oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,6]]},"published":{"date-parts":[[2014,6,1]]}}}